Anneke van Veen

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

TCTM van der Pouw Kraan, Anneke van Veen, LCM Boeije et al. · Genes and Immunity · 1999 · 291 citations

Life Sciences, Genetics, Immunology +16

Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial

Anke Lenferink, Job van der Palen, P.D.L.P.M. van der Valk et al. · European Respiratory Journal · 2019 · 56 citations · Full text

Nursing, Health Behavior, Internal Medicine +17

A comparison of salmeterol and formoterol in attenuating airway responses to short-acting β2-agonists

Anneke van Veen, F. Weller, E A Wierenga et al. · Pulmonary Pharmacology & Therapeutics · 2003 · 35 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers

Simone Hashimoto, Johannes A. Kroes, Katrien Eger et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis

Sarah Bendien, Johannes A. Kroes, Lotte H.G. van Hal et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 25 citations · Full text

Life Sciences, Immunology, Internal Medicine +15